Searched for
AHMEDABAD DRUGMAKER
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...- Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata MotorsIndian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...
- Zydus Lifesciences close to buying US oncology drug maker for $100 to 150 million: SourcesIndian drug maker Zydus Lifesciences is close to acquiring a US company. The deal is expected to be between $100 to $150 million. This acqu...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Zydus partners with Lupin to co-market generic semaglutide in IndiaZydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...
- Delhi HC clears Zydus to sell biosimilar of BMS cancer drug NivolumabThe Delhi High Court has permitted Zydus Lifesciences to produce and market a biosimilar cancer drug. This decision comes as the patent for...
- Glenmark, Granules, Zydus recall products in US over manufacturing issues: USFDAIndian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...
- Eris Lifesciences' unit gets Brazil health regulator nodEris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...
- Zydus Lifesciences gets 6 observations from USFDA for API plantThe US Food and Drug Administration (USFDA) conducted the inspection from December 14 to December 22, 2023. The inspection closed with six ...
- Amneal Pharma to set up plant in GujaratThe NYSE-listed, $2-billion drug maker by sales (2020), which is foraying into India's domestic formulations segment with focus on biologic...
- Lupin shuts manufacturing drug plant after 17 employees test positive for Covid-19The company has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employe...
- Cadila Pharmaceuticals to set up SPV for funding innovation based startupsAhmedabad-based drug company, is looking for setting up a SPV for funding innovation done by individual or start-up firms in the field of d...
- Intas Pharmaceuticals prices generic onco-drug at one-fifth of current costIn MDS, the bone marrow does not make enough healthy blood cells and there are abnormal cells present, leading to leukaemia in advanced sta...
- Roselabs talks with PEs, inks Brazilian dealZameer Agrawal, director, Roselabs Biosciences Ltd, said, "We have recently entered into a $20 million contract supply deal with a Brazilia...
- West-Coast Pharma enters nutraceutical marketWest-Coast Pharmaceuticals will begin with some 40 products from own formulations under the brand name HealthVit.
- ChrysCapital, Blackstone and Advent Capital in race to buy stake in Intas Pharma for Rs 250 crore3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.
- Drugmakers revive production of H1N1 vaccineZydus Cadila, Panacea Biotech and Serum Institute have resumed production of the swine flu vaccine as the once-pandemic disease threatens t...
- Drug cos eye US entry after FDA checksThe US drug regulator has inspected the manufacturing plants of at least half-a-dozen Indian drugmakers, raising hopes that these companies...
- Drug market grows 20% in H1; foreign firms tighten holdA series of buyouts by foreign heavy weights, including Ranbaxy and Piramal Healthcare has resulted in foreign MNCs taking three slots amon...
- Lupin can't sell pill in US, Teva files patent suitIsraeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...
Load More
